Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2 Dose Escalation and Expansion Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients With Advanced Solid Tumors or Non-Small Cell Lung, Biliary Tract, and Bladder Cancer

NCT02240238 is registered in ClinicalTrials.gov with NanoCarrier Co., Ltd. as lead sponsor.

NCT NCT02240238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02240238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2 Dose Escalation and Expansion Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients With Advanced Solid Tumors or Non-Small Cell Lung, Biliary Tract, and Bladder Cancer
Lead sponsor
NanoCarrier Co., Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2014
Completion date
May 6, 2019
Enrollment
119 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors